Paul Spence's most recent trade in OptiNose Inc was a trade of 102,813 Common Stock done . Disclosure was reported to the exchange on May 21, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| OptiNose Inc | Paul Spence | Chief Commercial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 May 2025 | 102,813 | 0 (0%) | 0% | - | Common Stock | |
| OptiNose Inc | Paul Spence | Chief Commercial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 May 2025 | 33,333 | 0 | - | - | Stock Option (Right to Buy) | |
| OptiNose Inc | Paul Spence | Chief Commercial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 May 2025 | 8,525 | 0 | - | - | Stock Option (Right to Buy) | |
| OptiNose Inc | Paul Spence | Chief Commercial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 May 2025 | 8,422 | 0 | - | - | Stock Option (Right to Buy) | |
| OptiNose Inc | Paul Spence | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 5.29 per share. | 04 Mar 2025 | 1,223 | 32,647 (0%) | 0% | 5.3 | 6,470 | Common Stock |
| OptiNose Inc | Paul Spence | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 17,025 | 33,870 (0%) | 0% | 0 | Common Stock | |
| OptiNose Inc | Paul Spence | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 8,525 | 8,525 | - | - | Stock Option (Right to Buy) | |
| OptiNose Inc | Paul Spence | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 252,675 | 252,675 (0%) | 0% | 0 | Common Stock | |
| OptiNose Inc | Spence Paul | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 126,338 | 126,338 | - | - | Stock Option (Right to Buy) | |
| OptiNose Inc | Paul Spence | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2022 | 500,000 | 500,000 | - | - | Stock Option (Right to Buy) |